✦ LIBER ✦

913 EXTENDING THE TREATMENT DURATION OF PEGINTERFERON ALFA-2A THERAPY TO 72 WEEKS INCREASES THE RATE OF HBeAg SEROCONVERSION IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B

✍ Scribed by Y.-Y. Zhu; J. Dong; Y.-T. Chen; J. Chen; J.-J. Jiang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

917 ON-TREATMENT MONITORING OF HBsAg LEV

✍ G.K.K. Lau; P. Marcellin; M. Brunetto; T. Piratvisuth; H.-P. Kapprell; D. Messin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

O115 PEGINTERFERON LAMBDA FOR THE TREATM

✍ Chan, H.L.; Ahn, S.H.; Chang, T.-T.; Peng, C.-Y.; Wong, D.; Coffin, C.S.; Lim, S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

PIN5 THE COST EFFECTIVENESS ANALYSIS OF

✍ E Kowalik; M Niewada; M Jakubczyk; A Horban; H Berak; M Szkultecka-Debek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

714 HBSAG LEVELS DURING THE FIRST 24 WEE

✍ I. Goulis; E. Akriviadis; S. Karatapanis; M. Deutsch; G. Dalekos; M. Raptopoulou 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

PIN60 COST-EFFECTIVENESS OF PEGINTERFERO

✍ Sheng, F 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

749 EFFICACY AND SAFETY OF PEGINTERFERON

✍ Hou, J.; Ma, H.; Sun, J.; Xie, Q.; Xie, Y.; Sun, Y.; Wang, H.; Shi, G.; Wan, M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 219 KB